Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen
Top
Quality of Life Research
Gepubliceerd in:

18-10-2023

Personal and perceived stigma in relation to diverse domains of quality of life among patients with major depressive disorder having residual symptoms: a hospital-based cross-sectional study in Thailand

Auteurs: Jarurin Pitanupong, Warut Aunjitsakul

Gepubliceerd in: Quality of Life Research | Uitgave 2/2024

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Depression is a debilitating disease with residual symptoms that negatively impact patients’ quality of life (QoL). Stigma is associated with poor QoL; however, knowledge regarding stigma subtypes and each QoL domain concerning residual depression is limited. We aimed to investigate the association of residual depression symptoms with QoL and stigma among patients with major depressive disorder (MDD).

Methods

This cross-sectional study was conducted at an outpatient clinic among patients with MDD (March–July 2022). We administered the Thai version of the Patient Health Questionnaire-9, World Health Organization Quality of Life Brief, and Mental Health Consumers’ Experience of Stigma to assess patients’ levels of depression, QoL, and personal and perceived stigma, respectively. We performed correlational and logistic regression analyses to evaluate the association of demographics, QoL, stigma, and stress with residual depression.

Results

Of 384 patients with MDD (median age = 39.5, females = 73.2%), 54.4% had residual depression. Among those with residual depression, depression was negatively correlated with QoL (ρ = – 0.58, p < 0.001) and positively correlated with stigma (ρ = 0.24, p < 0.001). The risk of residual depression decreased as the QoL score increased (adjusted OR per 1-point increase 0.93 [0.91, 0.96], p < 0.001); residual depression was significantly associated with personal stigma.

Conclusion

Stigma and QoL exhibit an inverse relationship. Physical-, psychological-, and environmental-health domains of QoL and personal stigma are key contributing factors to residual MDD symptoms. Improvement of QoL and stigma requires further theoretical research and should be of concern in clinical practice. Longitudinal studies on relatively diverse populations and subsyndromal symptoms are needed.
vorige artikel The effect of depressive symptoms on quality of life and its different facets in the oldest age population: evidence from the AgeQualiDe prospective cohort study
volgende artikel Mapping the 12-item World Health Organization disability assessment schedule 2.0 (WHODAS 2.0) onto the assessment of quality of life (AQoL)-4D utilities
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Ferrari, A. J., Somerville, A. J., Baxter, A. J., Norman, R., Patten, S. B., Vos, T., & Whiteford, H. A. (2013). Global variation in the prevalence and incidence of major depressive disorder: A systematic review of the epidemiological literature. Psychological Medicine, 43(3), 471–481.CrossRefPubMed
2.
Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., Bang-Jensen, B. L., Bertolacci, G. J., Bloom, S. S., Castellano, R., Castro, E., Chakrabarti, S., Chattopadhyay, J., Cogen, R. M., Collins, J. K., & Ferrari, A. J. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet, 398(10312), 1700–1712.CrossRef
3.
Lim, G. Y., Tam, W. W., Lu, Y., Ho, C. S., Zhang, M. W., & Ho, R. C. (2018). Prevalence of depression in the community from 30 countries between 1994 and 2014. Scientific Reports, 8(1), 2861.CrossRefPubMedPubMedCentralADS
4.
Thongtang, O., Sukhatunga, K., Ngamthipwatthana, T., Chulakadabba, S., Vuthiganond, S., Pooviboonsuk, P., Kooptiwoot, S., & Phattharayuttawat, S. (2002). Prevalence and incidence of depression in the Thai elderly. Journal of the Medical Association of Thailand Chotmaihet Thangphaet, 85(5), 540–544.PubMed
5.
Chomchoei, C., Apidechkul, T., Keawdounglek, V., Wongfu, C., Khunthason, S., Kullawong, N., Tamornpark, R., Upala, P., & Yeemard, F. (2020). Prevalence of and factors associated with depression among hill tribe individuals aged 30 years and over in Thailand. Heliyon, 6(6), e04273.CrossRefPubMedPubMedCentral
6.
Gautam, S., Jain, A., Gautam, M., Vahia, V. N., & Grover, S. (2017). Clinical practice guidelines for the management of depression. Indian Journal of Psychiatry, 59(Suppl 1), S34–S50.PubMedPubMedCentral
7.
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., McInerney, S. J., McIntosh, D., Milev, R. V., Müller, D. J., Parikh, S. V., Pearson, N. L., Ravindran, A. V., & Uher, R. (2016). Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatments. Canadian Journal of Psychiatry, 61(9), 540–560.CrossRefPubMed
8.
9.
Balestri, M., Calati, R., Souery, D., Kautzky, A., Kasper, S., Montgomery, S., Zohar, J., Mendlewicz, J., & Serretti, A. (2016). Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study. Journal of Affective Disorders, 189, 224–232.CrossRefPubMed
10.
Pitanupong, J., Sathaporn, K., & Tepsuan, L. (2022). Residual symptoms and their associated factors among Thai patients with depression: A multihospital-based survey. Annals of General Psychiatry, 21(1), 50.CrossRefPubMedPubMedCentral
11.
Romera, I., Pérez, V., Ciudad, A., Caballero, L., Roca, M., Polavieja, P., & Gilaberte, I. (2013). Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis. BMC Psychiatry, 13, 51.CrossRefPubMed
12.
Wang, Y., Wang, G., Zhang, N., Huang, J., Wu, W., Jia, F., Liu, T., Gao, C., Hu, J., Hong, W., & Fang, Y. (2020). Association between residual symptoms and social functioning in patients with depression. Comprehensive Psychiatry, 98, 152164.CrossRefPubMed
13.
Whooley, M. A., Kiefe, C. I., Chesney, M. A., Markovitz, J. H., Matthews, K., & Hulley, S. B. (2002). Depressive symptoms, unemployment, and loss of income: The CARDIA Study. Archives of Internal Medicine, 162(22), 2614–2620.CrossRefPubMed
14.
Hengartner, M. P., & Plöderl, M. (2018). Statistically significant antidepressant-placebo differences on subjective symptom-rating scales do not prove that the drugs work: Effect size and method bias matter! Frontiers in Psychiatry, 9, 517.CrossRefPubMedPubMedCentral
15.
Link, B. G., & Phelan, J. C. (2001). Conceptualizing stigma. Annual Review of Sociology, 27, 363–385.CrossRef
16.
Steger, M. F., & Kashdan, T. B. (2009). Depression and everyday social activity, belonging, and well-being. Journal of Counseling Psychology, 56(2), 289–300.CrossRefPubMedPubMedCentral
17.
Kupferberg, A., Bicks, L., & Hasler, G. (2016). Social functioning in major depressive disorder. Neuroscience & Biobehavioral Reviews, 69, 313–332.CrossRef
18.
Barney, L. J., Griffiths, K. M., Jorm, A. F., & Christensen, H. (2006). Stigma about depression and its impact on help-seeking intentions. Australian and New Zealand Journal of Psychiatry, 40(1), 51–54.CrossRefPubMed
19.
20.
Holubova, M., Prasko, J., Ociskova, M., Marackova, M., Grambal, A., & Slepecky, M. (2016). Self-stigma and quality of life in patients with depressive disorder: A cross-sectional study. Neuropsychiatric Disease and Treatment, 12, 2677–2687.CrossRefPubMedPubMedCentral
21.
Sun, Y., Chen, G., Wang, L., Li, N., Srisurapanont, M., Hong, J. P., Hatim, A., Chen, C. H., Udomratn, P., Bae, J. N., Fang, Y. R., Chua, H. C., Liu, S. I., George, T., Bautista, D., Chan, E., Rush, A. J., Yang, H., Su, Y. A., & Si, T. M. (2019). Perception of stigma and its associated factors among patients with major depressive disorder: A multicenter survey from an Asian population. Frontiers in Psychiatry, 10, 321.CrossRefPubMedPubMedCentral
22.
23.
Wahl, O. F. (1999). Mental health consumers’ experience of stigma. Schizophrenia Bulletin, 25(3), 467–478.CrossRefPubMed
24.
Wannachat, O. (2016). Life skills as perceived by caregivers, social support and perceived stigma among persons with schizophrenia. Chiangmai University.
25.
World Health Organization. Division of Mental, H. (1996). WHOQOL-BREF: Introduction, administration, scoring and generic version of the assessment: Field trial version, December 1996. World Health Organization.
26.
27.
Lovibond, P. F., & Lovibond, S. H. (1995). The structure of negative emotional states: Comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories. Behaviour Research and Therapy, 33(3), 335–343.CrossRefPubMed
28.
Oei, T. P., Sawang, S., Goh, Y. W., & Mukhtar, F. (2013). Using the depression anxiety stress scale 21 (DASS-21) across cultures. International Journal of Psychology, 48(6), 1018–1029.CrossRefPubMed
29.
Yang, L., Zhao, Y., Wang, Y., Liu, L., Zhang, X., Li, B., & Cui, R. (2015). The effects of psychological stress on depression. Current Neuropharmacology, 13(4), 494–504.CrossRefPubMedPubMedCentral
30.
Ravindran, A. V., Matheson, K., Griffiths, J., Merali, Z., & Anisman, H. (2002). Stress, coping, uplifts, and quality of life in subtypes of depression: A conceptual frame and emerging data. Journal of Affective Disorders, 71(1–3), 121–130.CrossRefPubMed
31.
Bostwick, J. M., & Pankratz, V. S. (2000). Affective disorders and suicide risk: A reexamination. American Journal of Psychiatry, 157(12), 1925–1932.CrossRefPubMed
32.
Hiranyatheb, T., Nakawiro, D., Wongpakaran, T., Wongpakaran, N., Bookkamana, P., Pinyopornpanish, M., Saisavoey, N., Wannarit, K., Satthapisit, S., & Tanchakvaranont, S. (2016). The impact of residual symptoms on relapse and quality of life among Thai depressive patients. Neuropsychiatric Disease and Treatment, 12, 3175–3181.CrossRefPubMedPubMedCentral
33.
Mackenzie, C. S., Heath, P. J., Vogel, D. L., & Chekay, R. (2019). Age differences in public stigma, self-stigma, and attitudes toward seeking help: A moderated mediation model. Journal of Clinical Psychology, 75(12), 2259–2272.CrossRefPubMed
34.
Hansson, L. (2002). Quality of life in depression and anxiety. International Review of Psychiatry, 14(3), 185–189.CrossRef
35.
El-Badri, S., & Mellsop, G. (2007). Stigma and quality of life as experienced by people with mental illness. Australasian Psychiatry, 15(3), 195–200.CrossRefPubMed
36.
Oliveira, S. E., Carvalho, H., & Esteves, F. (2016). Internalized stigma and quality of life domains among people with mental illness: The mediating role of self-esteem. Journal of Mental Health, 25(1), 55–61.CrossRefPubMed
Metagegevens
Titel
Personal and perceived stigma in relation to diverse domains of quality of life among patients with major depressive disorder having residual symptoms: a hospital-based cross-sectional study in Thailand
Auteurs
Jarurin Pitanupong
Warut Aunjitsakul
Publicatiedatum
18-10-2023
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 2/2024
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-023-03527-6

Andere artikelen Uitgave 2/2024

Caught between pity, explicit bias, and discrimination: a qualitative study on the impact of stigma on the quality of life of persons living with sickle cell disease in three African countries

  • Open Access

Quality of life of the Canadian population using the VR-12: population norms for health utility values, summary component scores and domain scores

  • Open Access

Perceived health- related quality of life in persons with multiple sclerosis with and without a vascular comorbidity

Quality of life in postmenopausal women with osteoporosis and osteopenia: associations with bone microarchitecture and nutritional status

A leaky gut contributes to reduced sarcopenia-related quality of life (SarQoL) in geriatric older adults

The impact of a neuromuscular rehabilitation programme on the quality of life of patients with acute coronary syndrome and its relationship with sexual dysfunction: a randomised controlled trial